Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 396-408

  Lee, Sik ^a   Kim, Won ^a   Moon, Sang Ok ^a   Sung, Mi Jeong ^a   Kim, Duk Hoon ^a   Kang, Kyung Pyo ^a   Jang, Kyu Yoon ^a   Lee, Sang Yong ^a   Park, Byung Hyun ^a   Koh, Gou Young ^b   Park, Sung Kwang ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

COMP angiopoietin 1; Diabetic db db mouse; Inflammation; Kidney

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; BETA GALACTOSIDASE; CARTILAGE OLIGOMERIC MATRIX PROTEIN ANGIOPOIETIN 1; CELL ADHESION MOLECULE; DNA; FIBRONECTIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADIPOCYTE; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CELL GROWTH; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET RESTRICTION; DNA BINDING; DRUG POTENCY; DRUG SOLUBILITY; DRUG STABILITY; ENDOTHELIUM CELL; EPIDIDYMIS FAT; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MACROPHAGE; MALE; MESANGIUM CELL; MONOCYTE; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENAL PROTECTION; TISSUE DISTRIBUTION; UMBILICAL VEIN; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CHEMOKINE CCL2; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; MACROPHAGES; MALE; MICE; NF-KAPPA B; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 33846677486     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl598     Document Type: Article

References (20)

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341: 1127-1133
2. Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 2006; 17: 368-377
3. Satchell SC, Harper SJ, Tooke JE et al. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002; 13: 544-550
4. Yamamoto Y, Maeshima Y, Kitayama H et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004; 53: 1831-1840
5. Kim I, Moon SO, Park SK, Chae SW, Koh GY. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001; 89: 477-479
6. Takazawa Y, Maeshima Y, Kitayama H et al. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors. Kidney Int 2005; 68: 704-722
7. Cho CH, Kammerer RA, Lee HJ et al. COMP-Angl: A designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 2004; 101: 5547-5552
8. Cho CH, Kammerer RA, Lee HJ et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 5553-5558
9. Chen HC, Farese RV,Jr. Determination of adipocyte size by computer image analysis. J Lipid Res 2002; 43: 986-989
10. Sung MJ, Kim W, Ahn SY et al. Protective effect of α-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Cir Res 2005; 97: 880-890
11. Cho CH, Kim KE, Byun JH et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 2005; 97: 86-94
12. Shibuya K, Kanasaki K, Motohide I et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 2005; 54: 838-845
13. Hughes DP, Marron MB, Brindle NP. The anti-inflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kB inhibitor ABIN-2. Circ Res 2003; 92: 630-636
14. Okada S, Shikata K, Matsuda M et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003; 52: 2586-2593
15. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005; 16: 1711-1722
16. Yozai K, Shikata K, Sasaki M et al. Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol 2005; 16: 3326-3338
17. Joussen AM, Poulaki V, Tsujikawa A et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002; 160: 1683-1693
18. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111: 97-105
19. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology. Eur J Clin Invest 2004; 34: 785-796
20. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005; 289: F645-F659